Industry: Service & Software
Published Date: 2025-02-20
Pages: 73 Pages
Report ld: 4018468
Request Sample
Customized Report
The global market for Ovarian Reserve Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Declining follicular pool and oocyte quality specially in the mid to late thirties.
This age-related decline of follicles in the human ovary is supposed to be more than double when numbers fall below a critical figure of 25,000 at ~37.5 years of age. According to World Health Organization (WHO), the number of women age 60 and over will increase from about 336 million in 2000 to just over 1 billion in 2050.
Moreover, safety and efficacy associated with ovarian reserve tests is likely to increase the demand in the near future. Manufacturers are also developing home testing kits for ovarian reserve test also provides easy accessibility and availability for checkups which is likely to rise the demand.
Ovarian surgeries also play an important role in driving the market, since removal of cysts can also result in diminished ovarian follicle in women. Thus, all these factors are likely to increase the market growth in the forecast period.
North American market for Ovarian Reserve Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ovarian Reserve Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Ovarian Reserve Test in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Ovarian Reserve Test include Beckman Coulter, Fujirebio, F. Hoffmann-La Roche Ltd, Everlywell, LabCorp, VIDAS, Modern Fertility, Future Family, LetsGetChecked, EggQ, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ovarian Reserve Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ovarian Reserve Test.
The Ovarian Reserve Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ovarian Reserve Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ovarian Reserve Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ovarian Reserve Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ovarian Reserve Test Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Follicle Stimulating Hormone (FSH) Testing
1.2.3 Anti-Mullerian hormone (AMH) Testing
1.2.4 Antral Follicle Count Testing
1.2.5 Basal Follicle Stimulating Hormone Testing
1.3 Market by Application
1.3.1 Global Ovarian Reserve Test Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 IVF Centers
1.3.4 Diagnostic Centres
1.3.5 Ambulatory Surgical Centres
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ovarian Reserve Test Market Perspective (2020-2031)
2.2 Global Ovarian Reserve Test Growth Trends by Region
2.2.1 Global Ovarian Reserve Test Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ovarian Reserve Test Historic Market Size by Region (2020-2025)
2.2.3 Ovarian Reserve Test Forecasted Market Size by Region (2026-2031)
2.3 Ovarian Reserve Test Market Dynamics
2.3.1 Ovarian Reserve Test Industry Trends
2.3.2 Ovarian Reserve Test Market Drivers
2.3.3 Ovarian Reserve Test Market Challenges
2.3.4 Ovarian Reserve Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ovarian Reserve Test Players by Revenue
3.1.1 Global Top Ovarian Reserve Test Players by Revenue (2020-2025)
3.1.2 Global Ovarian Reserve Test Revenue Market Share by Players (2020-2025)
3.2 Global Ovarian Reserve Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ovarian Reserve Test Revenue
3.4 Global Ovarian Reserve Test Market Concentration Ratio
3.4.1 Global Ovarian Reserve Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ovarian Reserve Test Revenue in 2024
3.5 Global Key Players of Ovarian Reserve Test Head office and Area Served
3.6 Global Key Players of Ovarian Reserve Test, Product and Application
3.7 Global Key Players of Ovarian Reserve Test, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ovarian Reserve Test Breakdown Data by Type
4.1 Global Ovarian Reserve Test Historic Market Size by Type (2020-2025)
4.2 Global Ovarian Reserve Test Forecasted Market Size by Type (2026-2031)
5 Ovarian Reserve Test Breakdown Data by Application
5.1 Global Ovarian Reserve Test Historic Market Size by Application (2020-2025)
5.2 Global Ovarian Reserve Test Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ovarian Reserve Test Market Size (2020-2031)
6.2 North America Ovarian Reserve Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ovarian Reserve Test Market Size by Country (2020-2025)
6.4 North America Ovarian Reserve Test Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ovarian Reserve Test Market Size (2020-2031)
7.2 Europe Ovarian Reserve Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ovarian Reserve Test Market Size by Country (2020-2025)
7.4 Europe Ovarian Reserve Test Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ovarian Reserve Test Market Size (2020-2031)
8.2 Asia-Pacific Ovarian Reserve Test Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ovarian Reserve Test Market Size by Region (2020-2025)
8.4 Asia-Pacific Ovarian Reserve Test Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ovarian Reserve Test Market Size (2020-2031)
9.2 Latin America Ovarian Reserve Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ovarian Reserve Test Market Size by Country (2020-2025)
9.4 Latin America Ovarian Reserve Test Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ovarian Reserve Test Market Size (2020-2031)
10.2 Middle East & Africa Ovarian Reserve Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ovarian Reserve Test Market Size by Country (2020-2025)
10.4 Middle East & Africa Ovarian Reserve Test Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Beckman Coulter
11.1.1 Beckman Coulter Company Details
11.1.2 Beckman Coulter Business Overview
11.1.3 Beckman Coulter Ovarian Reserve Test Introduction
11.1.4 Beckman Coulter Revenue in Ovarian Reserve Test Business (2020-2025)
11.1.5 Beckman Coulter Recent Development
11.2 Fujirebio
11.2.1 Fujirebio Company Details
11.2.2 Fujirebio Business Overview
11.2.3 Fujirebio Ovarian Reserve Test Introduction
11.2.4 Fujirebio Revenue in Ovarian Reserve Test Business (2020-2025)
11.2.5 Fujirebio Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Ovarian Reserve Test Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Ovarian Reserve Test Business (2020-2025)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Everlywell
11.4.1 Everlywell Company Details
11.4.2 Everlywell Business Overview
11.4.3 Everlywell Ovarian Reserve Test Introduction
11.4.4 Everlywell Revenue in Ovarian Reserve Test Business (2020-2025)
11.4.5 Everlywell Recent Development
11.5 LabCorp
11.5.1 LabCorp Company Details
11.5.2 LabCorp Business Overview
11.5.3 LabCorp Ovarian Reserve Test Introduction
11.5.4 LabCorp Revenue in Ovarian Reserve Test Business (2020-2025)
11.5.5 LabCorp Recent Development
11.6 VIDAS
11.6.1 VIDAS Company Details
11.6.2 VIDAS Business Overview
11.6.3 VIDAS Ovarian Reserve Test Introduction
11.6.4 VIDAS Revenue in Ovarian Reserve Test Business (2020-2025)
11.6.5 VIDAS Recent Development
11.7 Modern Fertility
11.7.1 Modern Fertility Company Details
11.7.2 Modern Fertility Business Overview
11.7.3 Modern Fertility Ovarian Reserve Test Introduction
11.7.4 Modern Fertility Revenue in Ovarian Reserve Test Business (2020-2025)
11.7.5 Modern Fertility Recent Development
11.8 Future Family
11.8.1 Future Family Company Details
11.8.2 Future Family Business Overview
11.8.3 Future Family Ovarian Reserve Test Introduction
11.8.4 Future Family Revenue in Ovarian Reserve Test Business (2020-2025)
11.8.5 Future Family Recent Development
11.9 LetsGetChecked
11.9.1 LetsGetChecked Company Details
11.9.2 LetsGetChecked Business Overview
11.9.3 LetsGetChecked Ovarian Reserve Test Introduction
11.9.4 LetsGetChecked Revenue in Ovarian Reserve Test Business (2020-2025)
11.9.5 LetsGetChecked Recent Development
11.10 EggQ
11.10.1 EggQ Company Details
11.10.2 EggQ Business Overview
11.10.3 EggQ Ovarian Reserve Test Introduction
11.10.4 EggQ Revenue in Ovarian Reserve Test Business (2020-2025)
11.10.5 EggQ Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Ovarian Reserve Test was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 110
USD 3950.00
(Single User License)
The global Ovarian Reserve Test market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 103
USD 2900.00
(Single User License)
The global Ovarian Reserve Test market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 120
USD 4900.00
(Single User License)
The global market for Ovarian Reserve Test was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 99
USD 3950.00
(Single User License)
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published Date: 2024-04-16
Pages: 112
USD 4900.00
(Single User License)
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published Date: 2024-02-21
Pages: 111
USD 3950.00
(Single User License)
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published Date: 2024-01-08
Pages: 84
USD 2900.00
(Single User License)
The global market for Ovarian Reserve Test was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 110
The global Ovarian Reserve Test market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 103
The global Ovarian Reserve Test market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 120
The global market for Ovarian Reserve Test was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 99
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published: 2024-04-16
Pages: 112
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published: 2024-02-21
Pages: 111
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published: 2024-01-08
Pages: 84
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now